1 Market Overview
1.1 Product Overview and Scope of Live and Attenuated Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Live and Attenuated Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Pediatric Vaccine
1.3.3 Adult Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Live and Attenuated Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Diagnostic Centers
1.4.5 Research Institute
1.4.6 Others
1.5 Global Live and Attenuated Vaccine Market Size & Forecast
1.5.1 Global Live and Attenuated Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Live and Attenuated Vaccine Sales Quantity (2018-2029)
1.5.3 Global Live and Attenuated Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Live and Attenuated Vaccine Product and Services
2.1.4 GlaxoSmithKline Live and Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 Merck & Co.
2.2.1 Merck & Co. Details
2.2.2 Merck & Co. Major Business
2.2.3 Merck & Co. Live and Attenuated Vaccine Product and Services
2.2.4 Merck & Co. Live and Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck & Co. Recent Developments/Updates
2.3 Pfizer, Inc
2.3.1 Pfizer, Inc Details
2.3.2 Pfizer, Inc Major Business
2.3.3 Pfizer, Inc Live and Attenuated Vaccine Product and Services
2.3.4 Pfizer, Inc Live and Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer, Inc Recent Developments/Updates
2.4 Astellas Pharma Inc
2.4.1 Astellas Pharma Inc Details
2.4.2 Astellas Pharma Inc Major Business
2.4.3 Astellas Pharma Inc Live and Attenuated Vaccine Product and Services
2.4.4 Astellas Pharma Inc Live and Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Astellas Pharma Inc Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Live and Attenuated Vaccine Product and Services
2.5.4 Johnson & Johnson Live and Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 CSL Limited
2.6.1 CSL Limited Details
2.6.2 CSL Limited Major Business
2.6.3 CSL Limited Live and Attenuated Vaccine Product and Services
2.6.4 CSL Limited Live and Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 CSL Limited Recent Developments/Updates
2.7 Emergent BioSolutions, Inc.
2.7.1 Emergent BioSolutions, Inc. Details
2.7.2 Emergent BioSolutions, Inc. Major Business
2.7.3 Emergent BioSolutions, Inc. Live and Attenuated Vaccine Product and Services
2.7.4 Emergent BioSolutions, Inc. Live and Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Emergent BioSolutions, Inc. Recent Developments/Updates
2.8 MedImmune, LLC
2.8.1 MedImmune, LLC Details
2.8.2 MedImmune, LLC Major Business
2.8.3 MedImmune, LLC Live and Attenuated Vaccine Product and Services
2.8.4 MedImmune, LLC Live and Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 MedImmune, LLC Recent Developments/Updates
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Live and Attenuated Vaccine Product and Services
2.9.4 Sanofi Live and Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sanofi Recent Developments/Updates
2.10 Serum Institute
2.10.1 Serum Institute Details
2.10.2 Serum Institute Major Business
2.10.3 Serum Institute Live and Attenuated Vaccine Product and Services
2.10.4 Serum Institute Live and Attenuated Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Serum Institute Recent Developments/Updates
3 Competitive Environment: Live and Attenuated Vaccine by Manufacturer
3.1 Global Live and Attenuated Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Live and Attenuated Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Live and Attenuated Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Live and Attenuated Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Live and Attenuated Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Live and Attenuated Vaccine Manufacturer Market Share in 2022
3.5 Live and Attenuated Vaccine Market: Overall Company Footprint Analysis
3.5.1 Live and Attenuated Vaccine Market: Region Footprint
3.5.2 Live and Attenuated Vaccine Market: Company Product Type Footprint
3.5.3 Live and Attenuated Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Live and Attenuated Vaccine Market Size by Region
4.1.1 Global Live and Attenuated Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Live and Attenuated Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Live and Attenuated Vaccine Average Price by Region (2018-2029)
4.2 North America Live and Attenuated Vaccine Consumption Value (2018-2029)
4.3 Europe Live and Attenuated Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Live and Attenuated Vaccine Consumption Value (2018-2029)
4.5 South America Live and Attenuated Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Live and Attenuated Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Live and Attenuated Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Live and Attenuated Vaccine Consumption Value by Type (2018-2029)
5.3 Global Live and Attenuated Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Live and Attenuated Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Live and Attenuated Vaccine Consumption Value by Application (2018-2029)
6.3 Global Live and Attenuated Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Live and Attenuated Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Live and Attenuated Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Live and Attenuated Vaccine Market Size by Country
7.3.1 North America Live and Attenuated Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Live and Attenuated Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Live and Attenuated Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Live and Attenuated Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Live and Attenuated Vaccine Market Size by Country
8.3.1 Europe Live and Attenuated Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Live and Attenuated Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Live and Attenuated Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Live and Attenuated Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Live and Attenuated Vaccine Market Size by Region
9.3.1 Asia-Pacific Live and Attenuated Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Live and Attenuated Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Live and Attenuated Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Live and Attenuated Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Live and Attenuated Vaccine Market Size by Country
10.3.1 South America Live and Attenuated Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Live and Attenuated Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Live and Attenuated Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Live and Attenuated Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Live and Attenuated Vaccine Market Size by Country
11.3.1 Middle East & Africa Live and Attenuated Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Live and Attenuated Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Live and Attenuated Vaccine Market Drivers
12.2 Live and Attenuated Vaccine Market Restraints
12.3 Live and Attenuated Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Live and Attenuated Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Live and Attenuated Vaccine
13.3 Live and Attenuated Vaccine Production Process
13.4 Live and Attenuated Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Live and Attenuated Vaccine Typical Distributors
14.3 Live and Attenuated Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Live and Attenuated Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Live and Attenuated Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Live and Attenuated Vaccine Product and Services
Table 6. GlaxoSmithKline Live and Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 9. Merck & Co. Major Business
Table 10. Merck & Co. Live and Attenuated Vaccine Product and Services
Table 11. Merck & Co. Live and Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merck & Co. Recent Developments/Updates
Table 13. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer, Inc Major Business
Table 15. Pfizer, Inc Live and Attenuated Vaccine Product and Services
Table 16. Pfizer, Inc Live and Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer, Inc Recent Developments/Updates
Table 18. Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 19. Astellas Pharma Inc Major Business
Table 20. Astellas Pharma Inc Live and Attenuated Vaccine Product and Services
Table 21. Astellas Pharma Inc Live and Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Astellas Pharma Inc Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Live and Attenuated Vaccine Product and Services
Table 26. Johnson & Johnson Live and Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 29. CSL Limited Major Business
Table 30. CSL Limited Live and Attenuated Vaccine Product and Services
Table 31. CSL Limited Live and Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. CSL Limited Recent Developments/Updates
Table 33. Emergent BioSolutions, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Emergent BioSolutions, Inc. Major Business
Table 35. Emergent BioSolutions, Inc. Live and Attenuated Vaccine Product and Services
Table 36. Emergent BioSolutions, Inc. Live and Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Emergent BioSolutions, Inc. Recent Developments/Updates
Table 38. MedImmune, LLC Basic Information, Manufacturing Base and Competitors
Table 39. MedImmune, LLC Major Business
Table 40. MedImmune, LLC Live and Attenuated Vaccine Product and Services
Table 41. MedImmune, LLC Live and Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. MedImmune, LLC Recent Developments/Updates
Table 43. Sanofi Basic Information, Manufacturing Base and Competitors
Table 44. Sanofi Major Business
Table 45. Sanofi Live and Attenuated Vaccine Product and Services
Table 46. Sanofi Live and Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Sanofi Recent Developments/Updates
Table 48. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 49. Serum Institute Major Business
Table 50. Serum Institute Live and Attenuated Vaccine Product and Services
Table 51. Serum Institute Live and Attenuated Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Serum Institute Recent Developments/Updates
Table 53. Global Live and Attenuated Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Live and Attenuated Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Live and Attenuated Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Live and Attenuated Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Live and Attenuated Vaccine Production Site of Key Manufacturer
Table 58. Live and Attenuated Vaccine Market: Company Product Type Footprint
Table 59. Live and Attenuated Vaccine Market: Company Product Application Footprint
Table 60. Live and Attenuated Vaccine New Market Entrants and Barriers to Market Entry
Table 61. Live and Attenuated Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Live and Attenuated Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Live and Attenuated Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Live and Attenuated Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Live and Attenuated Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Live and Attenuated Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Live and Attenuated Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Live and Attenuated Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Live and Attenuated Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Live and Attenuated Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Live and Attenuated Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Live and Attenuated Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Live and Attenuated Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Live and Attenuated Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Live and Attenuated Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Live and Attenuated Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Live and Attenuated Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Live and Attenuated Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Live and Attenuated Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Live and Attenuated Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Live and Attenuated Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Live and Attenuated Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Live and Attenuated Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Live and Attenuated Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Live and Attenuated Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Live and Attenuated Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Live and Attenuated Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Live and Attenuated Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Live and Attenuated Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Live and Attenuated Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Live and Attenuated Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Live and Attenuated Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Live and Attenuated Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Live and Attenuated Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Live and Attenuated Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Live and Attenuated Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Live and Attenuated Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Live and Attenuated Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Live and Attenuated Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Live and Attenuated Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Live and Attenuated Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Live and Attenuated Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Live and Attenuated Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Live and Attenuated Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Live and Attenuated Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Live and Attenuated Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Live and Attenuated Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Live and Attenuated Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Live and Attenuated Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Live and Attenuated Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Live and Attenuated Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Live and Attenuated Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Live and Attenuated Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Live and Attenuated Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Live and Attenuated Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Live and Attenuated Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Live and Attenuated Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Live and Attenuated Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Live and Attenuated Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Live and Attenuated Vaccine Raw Material
Table 121. Key Manufacturers of Live and Attenuated Vaccine Raw Materials
Table 122. Live and Attenuated Vaccine Typical Distributors
Table 123. Live and Attenuated Vaccine Typical Customers
List of Figures
Figure 1. Live and Attenuated Vaccine Picture
Figure 2. Global Live and Attenuated Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Live and Attenuated Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Pediatric Vaccine Examples
Figure 5. Adult Vaccines Examples
Figure 6. Global Live and Attenuated Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Live and Attenuated Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Clinics Examples
Figure 10. Diagnostic Centers Examples
Figure 11. Research Institute Examples
Figure 12. Others Examples
Figure 13. Global Live and Attenuated Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Live and Attenuated Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Live and Attenuated Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Live and Attenuated Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Live and Attenuated Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Live and Attenuated Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Live and Attenuated Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Live and Attenuated Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Live and Attenuated Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Live and Attenuated Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Live and Attenuated Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Live and Attenuated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Live and Attenuated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Live and Attenuated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Live and Attenuated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Live and Attenuated Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Live and Attenuated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Live and Attenuated Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Live and Attenuated Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Live and Attenuated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Live and Attenuated Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Live and Attenuated Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Live and Attenuated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Live and Attenuated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Live and Attenuated Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Live and Attenuated Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Live and Attenuated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Live and Attenuated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Live and Attenuated Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Live and Attenuated Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Live and Attenuated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Live and Attenuated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Live and Attenuated Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Live and Attenuated Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 55. China Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Live and Attenuated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Live and Attenuated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Live and Attenuated Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Live and Attenuated Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Live and Attenuated Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Live and Attenuated Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Live and Attenuated Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Live and Attenuated Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Live and Attenuated Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Live and Attenuated Vaccine Market Drivers
Figure 76. Live and Attenuated Vaccine Market Restraints
Figure 77. Live and Attenuated Vaccine Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Live and Attenuated Vaccine in 2022
Figure 80. Manufacturing Process Analysis of Live and Attenuated Vaccine
Figure 81. Live and Attenuated Vaccine Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
